par Pantano, Francesco;Iuliani, Michele;Zoccoli, Alice;Fioramonti, Marco 
;De Lisi, Delia;Fioroni, Iacopo;Ribelli, Giulia;Santoni, Matteo;Vincenzi, Bruno;Tonini, Giuseppe;Santini, Daniele
Référence Expert opinion on emerging drugs, 20, 4, page (637-651)
Publication Publié, 2015
;De Lisi, Delia;Fioroni, Iacopo;Ribelli, Giulia;Santoni, Matteo;Vincenzi, Bruno;Tonini, Giuseppe;Santini, DanieleRéférence Expert opinion on emerging drugs, 20, 4, page (637-651)
Publication Publié, 2015
Article révisé par les pairs
| Titre: |
|
| Auteur: | Pantano, Francesco; Iuliani, Michele; Zoccoli, Alice; Fioramonti, Marco; De Lisi, Delia; Fioroni, Iacopo; Ribelli, Giulia; Santoni, Matteo; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele |
| Informations sur la publication: | Expert opinion on emerging drugs, 20, 4, page (637-651) |
| Statut de publication: | Publié, 2015 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | bone metastases |
| bone target therapy | |
| osteoblast | |
| osteoclast | |
| MeSH keywords: | Animals |
| Antineoplastic Agents -- pharmacology -- therapeutic use | |
| Bone Density Conservation Agents -- pharmacology -- therapeutic use | |
| Bone Neoplasms -- drug therapy -- pathology -- secondary | |
| Denosumab -- pharmacology -- therapeutic use | |
| Diphosphonates -- pharmacology -- therapeutic use | |
| Drug Design | |
| Humans | |
| Molecular Targeted Therapy | |
| Survival Rate | |
| Tumor Microenvironment | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1472-8214 |
| info:doi/10.1517/14728214.2015.1062876 | |
| info:pmid/26113304 |
